Medtronic, Merck, Williams Companies And More: CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Anastasia Amoroso of JPMorgan Private Bank named iShares 7-10 Year Treasury Bond ETF IEF as her final trade.

Jason Snipe of Odyssey Capital Advisors said he likes Medtronic plc MDT here.

Medtronic recently issued weak guidance and announced the acquisition of EOFlow.

Don’t forget to check out our premarket coverage here.

Joseph Terranova of Virtus Investment Partners recommended buying Merck & Co., Inc. MRK here.

Merck recently announced data from the final pre-specified overall survival (OS) analysis of the pivotal Phase 3 CLEAR (Study 307)/KEYNOTE-581 trial investigating Keytruda (pembrolizumab) plus Eisai Co Ltd's ESALY Lenvima (lenvatinib) for the first-line treatment of advanced renal cell carcinoma (RCC).

Jenny Harrington of Gilman Hill Asset Management named The Williams Companies, Inc. WMB, which has a 6.25% yield.

Williams Companies recently posted better-than-expected results for its first quarter.

Price Action: Williams Companies shares rose 0.4% to settle at $28.66, while Merck shares rose 1.1% to close at $110.41 on Wednesday. Medtronic shares rose 0.3% to close at $82.76 during the Wednesday’s session.
Check This Out: Dollar General, Broadcom And 3 Stocks To Watch Heading Into Thursday

Photo via Shutterstock.